Free Trial

Personalis (PSNL) News Today

Personalis logo
$5.75 +0.49 (+9.32%)
(As of 12/20/2024 05:45 PM ET)
Lake Street Reaffirms Their Buy Rating on Personalis (PSNL)
Personalis price target raised to $11 from $9 at H.C. Wainwright
Personalis, Inc. stock logo
Personalis (NASDAQ:PSNL) Given New $11.00 Price Target at HC Wainwright
HC Wainwright increased their target price on Personalis from $9.00 to $11.00 and gave the company a "buy" rating in a report on Friday.
Personalis, Inc. stock logo
Needham & Company LLC Reiterates Buy Rating for Personalis (NASDAQ:PSNL)
Needham & Company LLC reissued a "buy" rating and set a $7.25 price objective on shares of Personalis in a research report on Friday.
Merck Buys $50 Million of Personalis Stock
Personalis Shares Surge After Merck's $50 Million Investment
Personalis (PSNL) Gets a Buy from Lake Street
Personalis and Tempus Expand Collaboration to Biopharma
Personalis, Inc. stock logo
Jacobs Levy Equity Management Inc. Reduces Stock Position in Personalis, Inc. (NASDAQ:PSNL)
Jacobs Levy Equity Management Inc. reduced its position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 44.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 405,670 shares of the company's stock a
Personalis, Inc. stock logo
166,788 Shares in Personalis, Inc. (NASDAQ:PSNL) Purchased by Walleye Capital LLC
Walleye Capital LLC bought a new position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 166,788 shares of the company's stock, valued at approximately $897,
Personalis, Inc. stock logo
GSA Capital Partners LLP Lowers Position in Personalis, Inc. (NASDAQ:PSNL)
GSA Capital Partners LLP cut its holdings in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 70.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 124,082 shares of the company's stock after selling 302,7
Cathie Wood’s ARK Investment bought 266.8K shares of Personalis today
Personalis, Inc. stock logo
FY2024 EPS Estimate for Personalis Decreased by Analyst
Personalis, Inc. (NASDAQ:PSNL - Free Report) - Equities research analysts at HC Wainwright decreased their FY2024 earnings estimates for shares of Personalis in a research note issued on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($1.37) per
Personalis, Inc. stock logo
FY2028 EPS Estimates for Personalis Cut by HC Wainwright
Personalis, Inc. (NASDAQ:PSNL - Free Report) - Research analysts at HC Wainwright decreased their FY2028 earnings per share estimates for Personalis in a report issued on Thursday, November 7th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of $0
Personalis, Inc. stock logo
Personalis, Inc. (NASDAQ:PSNL) Shares Bought by ARK Investment Management LLC
ARK Investment Management LLC increased its stake in Personalis, Inc. (NASDAQ:PSNL - Free Report) by 11.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,085,523 shares of the company's stock after purchasing an addit
Personalis Reports Solid Q3 Growth and Raises Revenue Outlook
TD Cowen Remains a Buy on Personalis (PSNL)
Key Takeaways From Personalis Analyst Ratings
Personalis, Inc. stock logo
Needham & Company LLC Reiterates "Buy" Rating for Personalis (NASDAQ:PSNL)
Needham & Company LLC restated a "buy" rating and set a $7.25 target price on shares of Personalis in a report on Thursday.
Personalis Reports Third Quarter 2024 Financial Results
Personalis (NASDAQ:PSNL) Stock, Option Chain
Personalis, Inc. stock logo
Personalis (PSNL) Set to Announce Earnings on Wednesday
Personalis (NASDAQ:PSNL) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639156)
The Proper Play On Personalis
Lake Street Keeps Their Buy Rating on Personalis (PSNL)
Personalis, Inc. stock logo
Personalis (NASDAQ:PSNL) Stock Price Down 0.7%
Personalis (NASDAQ:PSNL) Stock Price Down 0.7%
healthcare tempus AI computer stethoscope
Biotech Stock Soars 60% in 2024: Cathie Wood’s Bold Investment (PSNL)
Tempus AI is a hot healthcare stock that investors should be aware of. It is using AI to pursue "precision medicine", especially in cancer research.
Personalis, Inc. stock logo
Sumitomo Mitsui Trust Holdings Inc. Lowers Stock Position in Personalis, Inc. (NASDAQ:PSNL)
Sumitomo Mitsui Trust Holdings Inc. reduced its position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 9.4% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 885,417 shares of the co
Personalis (PSNL) Receives a Buy from BTIG
Personalis, Inc. stock logo
FY2024 EPS Estimates for Personalis, Inc. (NASDAQ:PSNL) Reduced by HC Wainwright
Personalis, Inc. (NASDAQ:PSNL - Free Report) - HC Wainwright cut their FY2024 earnings per share estimates for shares of Personalis in a report issued on Monday, August 19th. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings per share of ($1.01) for the year,
Lake Street Remains a Buy on Personalis (PSNL)
Personalis (PSNL) Receives a Buy from TD Cowen
Personalis, Inc. stock logo
Personalis (NASDAQ:PSNL) Price Target Increased to $9.00 by Analysts at HC Wainwright
HC Wainwright upped their target price on Personalis from $7.50 to $9.00 and gave the company a "buy" rating in a report on Monday.
Personalis, Inc. stock logo
Personalis, Inc. (NASDAQ:PSNL) Stock Position Lowered by Vanguard Group Inc.
Vanguard Group Inc. trimmed its position in shares of Personalis, Inc. (NASDAQ:PSNL - Free Report) by 8.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,904,165 shares of the company's stock after selling 165,929 shares
Personalis, Inc. stock logo
Personalis, Inc. (NASDAQ:PSNL) Short Interest Update
Personalis, Inc. (NASDAQ:PSNL - Get Free Report) was the target of a large growth in short interest in July. As of July 31st, there was short interest totalling 1,810,000 shares, a growth of 19.9% from the July 15th total of 1,510,000 shares. Based on an average trading volume of 885,000 shares, the days-to-cover ratio is currently 2.0 days.
Personalis Surges 19% on Expanded Tempus Partnership
Get Personalis News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

PSNL Media Mentions By Week

PSNL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PSNL
News Sentiment

0.33

0.60

Average
Medical
News Sentiment

PSNL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PSNL Articles
This Week

11

2

PSNL Articles
Average Week

Get Personalis News Delivered to You Automatically

Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:PSNL) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners